Statistics for Leveraging copper chelators as targeted therapy for BRAFV600E mutant thyroid cancer

Total visits

views
Leveraging copper chelators as targeted therapy for BRAFV600E mutant thyroid cancer 109

Total visits per month

views
December 2023 0
January 2024 0
February 2024 0
March 2024 0
April 2024 0
May 2024 0
June 2024 1

File Visits

views
Xu_duke_0066D_14732.pdf 152

Top country views

views
United States 7
Germany 5
China 3
France 1
United Kingdom 1

Top city views

views
Beijing 2
Saint Paul 2
Ashburn 1
Chaoyang 1
Durham 1
Houston 1
Pfafftown 1
Yulee 1